About Acusphere
Acusphere, Inc.™ is a specialty pharmaceutical company that develops new drugs and improved formulations of existing drugs using its proprietary porous microsphere technology. We are focused on developing proprietary drugs that can offer significant benefits such as improved safety and efficacy, increased patient compliance, greater ease of use, expanded indications or reduced cost.
June 24, 2009
Acusphere, Inc. Announces Amended Terms of Cephalon Agreements +more
May 19, 2009
Acusphere Announces Prepayment of Equipment Loans +more
March 31, 2009
Acusphere Reports Q4 2008 Recent Business Highlights, Business Priorities and Financial Results +more
March 11, 2009
Acusphere Receives Complete Response from FDA +more
March 03, 2009
Acusphere Announces Further Cost Reductions and Voluntary Filing of Form 15 to Suspend SEC Reporting Obligations +more
February 17, 2009
Acusphere Announces Change In Imagify Regulatory Strategy and Deferral of Near-Term Contractual Cash Payments +more
January 21, 2009
Acusphere Announces Publication of Imagify(TM) Phase 3 Trials in the European Journal of Echocardiography +more
December 10, 2008
Acusphere Announces Results of FDA Advisory Committee Meeting +more
